Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The objective of this prospective, randomized, double-blind, parallel-group,
placebo-controlled study is to determine the effectiveness of intranasal oxytocin in subjects
suffering from chronic daily headache. The primary outcome measure is the reduction in
headache intensity after drug administration; secondary outcome measures are the headache
symptoms, nausea, vomiting, photophobia, and phonophobia. Additional secondary outcome
measures are intake of rescue medication and patient satisfaction over a period of 24 hours.